Skip to main content
Livermore
Livermore
ZHEN

Davenport & Co LLC

SEC CIK
0000887777
Latest filing
Jul 13, 2026

SEEL holding history

Seelos Therapeutics, Inc. in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SEEL overviewAll 13F holders of SEELFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
11
Since Q1 2021
Holdings of SEEL by Davenport & Co LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−4,850−100.0%Sold outConverted for a 1-for-30 splitHolders
Q3 2023145,500$26.8K<0.1%+10,000+7.4%AddedHolders
Q2 2023135,500$161.9K<0.1%00.0%UnchangedHolders
Q1 2023135,500$93.7K<0.1%00.0%UnchangedHolders
Q4 2022135,500$92.0K<0.1%00.0%UnchangedHolders
Q3 2022135,500$140.0K<0.1%00.0%UnchangedHolders
Q2 2022135,500$92.0K<0.1%00.0%UnchangedHolders
Q1 2022135,500$114.0K<0.1%−75,000−35.6%ReducedHolders
Q4 2021210,500$343.0K<0.1%−48,000−18.6%ReducedHolders
Q3 2021258,500$623.0K<0.1%−15,000−5.5%ReducedHolders
Q2 2021273,500$722.0K<0.1%+31,000+12.8%AddedHolders
Q1 2021242,500$1.21M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.